167 related articles for article (PubMed ID: 19858097)
1. The signaling pathway leading to extracellular signal-regulated kinase 5 (ERK5) activation via G-proteins and ERK5-dependent neurotrophic effects.
Obara Y; Nakahata N
Mol Pharmacol; 2010 Jan; 77(1):10-6. PubMed ID: 19858097
[TBL] [Abstract][Full Text] [Related]
2. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells.
Obara Y; Nemoto W; Kohno S; Murata T; Kaneda N; Nakahata N
Cell Signal; 2011 Apr; 23(4):666-72. PubMed ID: 21130871
[TBL] [Abstract][Full Text] [Related]
4. Activation of the spinal extracellular signal-regulated kinase 5 signaling pathway contributes to morphine physical dependence in rats.
Wang CG; Lu XF; Wei JQ; Liu H; Zhang HX; Zhang LC; Cao JL
Neurosci Lett; 2011 Apr; 494(1):38-43. PubMed ID: 21356274
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.
Cavanaugh JE; Jaumotte JD; Lakoski JM; Zigmond MJ
J Neurosci Res; 2006 Nov; 84(6):1367-75. PubMed ID: 16941494
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cellular functions by the ERK5 signalling pathway.
Wang X; Tournier C
Cell Signal; 2006 Jun; 18(6):753-60. PubMed ID: 16376520
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors.
Gutkind JS
Sci STKE; 2000 Jul; 2000(40):re1. PubMed ID: 11752597
[TBL] [Abstract][Full Text] [Related]
9. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
[TBL] [Abstract][Full Text] [Related]
10. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
11. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos.
Scapoli L; Ramos-Nino ME; Martinelli M; Mossman BT
Oncogene; 2004 Jan; 23(3):805-13. PubMed ID: 14737115
[TBL] [Abstract][Full Text] [Related]
12. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis.
Kong AN; Yu R; Lei W; Mandlekar S; Tan TH; Ucker DS
Restor Neurol Neurosci; 1998 Jun; 12(2-3):63-70. PubMed ID: 12671299
[TBL] [Abstract][Full Text] [Related]
14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
15. The activation of extracellular signal-regulated protein kinase 5 in spinal cord and dorsal root ganglia contributes to inflammatory pain.
Xiao C; Zhang L; Cheng QP; Zhang LC
Brain Res; 2008 Jun; 1215():76-86. PubMed ID: 18486117
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation and properties of MAPKs.
Raman M; Chen W; Cobb MH
Oncogene; 2007 May; 26(22):3100-12. PubMed ID: 17496909
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of murine diphosphoinositol polyphosphate phosphohydrolase 1 attenuates signaling through the ERK1/2 pathway.
Chu C; Alapat D; Wen X; Timo K; Burstein D; Lisanti M; Shears S; Kohtz DS
Cell Signal; 2004 Sep; 16(9):1045-59. PubMed ID: 15212765
[TBL] [Abstract][Full Text] [Related]
18. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
19. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
[TBL] [Abstract][Full Text] [Related]
20. ERK5: structure, regulation and function.
Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
